Back
NextEra Energy 10K Form
Buy
54
NEE
NextEra Energy
Last Price:
77.29
Seasonality Move:
1.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-23 | 10Q | NEE/NextEra Energy Quarterly |
2024-02-16 | 10K | NEE/NextEra Energy Annual |
2023-11-07 | 10Q | NEE/NextEra Energy Quarterly |
2023-07-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-04-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-02-17 | 10K | NEE/NextEra Energy Annual |
Receive NEE News And Ratings
See the #1 stock for the next 7 days that we like better than NEE
NEE Financial Statistics
Sales & Book Value
Annual Sales: | $28.11B |
---|---|
Cash Flow: | $2.21B |
Price / Cash Flow: | 29.15 |
Annual Sales: | $24.34 |
Price / Book: | 3.14 |
Profitability
EPS (TTM): | 3.37910 |
---|---|
Net Income (TTM): | $6.95B |
Gross Margin: | $17.98B |
Return on Equity: | 11.88% |
Return on Assets: | 3.86% |
NextEra Energy Earnings Forecast
Key NextEra Energy Financial Ratios
- The Gross Profit Margin over the past 30 years for NEE is 63.94%.
- The Selling, General & Administrative Expenses for NEE have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 45.47% of Operating Income.
- The Net Earning history of NEE is 26.00% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 26 years.
NextEra Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electric Utilities |
Sector: | Utilities |
Current Symbol: | NEE |
CUSIP: | 65339F |
Website: | nexteraenergy.com |
Debt
Debt-to-Equity Ratio: | 1.65 |
---|---|
Current Ratio: | 0.41 |
Quick Ratio: | 0.24 |
Price-to-Earnings
Trailing P/E Ratio: | 21.22 |
---|---|
Forward P/E Ratio: | 20.74 |
NEE Technical Analysis vs Fundamental Analysis
Buy
54
NextEra Energy (NEE)
is a Buy
Is NextEra Energy a Buy or a Sell?
-
NextEra Energy stock is rated a Buy
The current NextEra Energy [NEE] share price is $76.88. The Score for NEE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.